Long‑term survival in metastatic malignant struma ovarii treated with oral chemotherapy: A case report

Ukita,Masayo; Nakai,Hidekatsu; Kotani,Yasushi; Tobiume,Takako; Koike,Eiji; Tsuji,Isao; Suzuki,Ayako; Mandai,Masaki

doi:10.3892/ol.2014.2587

December-2014 Volume 8 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December-2014 Volume 8 Issue 6

Full Size Image

Case Report Open Access

Long‑term survival in metastatic malignant struma ovarii treated with oral chemotherapy: A case report

Authors:
- Masayo Ukita
- Hidekatsu Nakai
- Yasushi Kotani
- Takako Tobiume
- Eiji Koike
- Isao Tsuji
- Ayako Suzuki
- Masaki Mandai
View Affiliations / Copyright

Affiliations: Department of Obstetrics and Gynecology, Kinki University Faculty of Medicine, Osakasayama, Osaka 589‑8511, Japan
Pages: 2458-2462
|
Published online on: October 3, 2014

https://doi.org/10.3892/ol.2014.2587
Expand metrics +

Abstract

Malignant struma ovarii is a rare type of ovarian tumor. Metastasis from malignant struma ovarii is rare and has only been documented in 5‑6% of cases. The natural history and optimal treatment strategy for malignant struma ovarii remains controversial due to its rarity. The current report presents the case of a 45‑year‑old female who presented with a tumor of the rib bone. Following resection, the postoperative diagnosis was a metastasizing thyroid carcinoma. No abnormality was detected in the thyroid gland, however, computed tomography revealed a tumor in the left ovary. The patient underwent a left salpingo‑oophorectomy and a wedge resection of the right ovary. The postoperative diagnosis was determined as a mature cystic teratoma with malignant struma ovarii (thyroid type, follicular carcinoma) of the left ovary and mature cystic teratoma of the right ovary. Four years subsequent to the initial diagnosis, multiple lung metastases were detected. The following chemotherapies were administered sequentially and intermittently: Tegafur‑uracil, paclitaxel/carboplatin and oral etoposide. During this period, the metastatic lesions extended into the bone and progressed slowly. The patient continues to survive with the disease and 24 years have passed since the initial diagnosis, 20 years following the diagnosis of multiple lung metastates. The present report describes a rare case of malignant struma ovarii in which surgical resection and pathological examination of a metastatic rib tumor resulted in the identification of the primary ovarian lesion. The clinical behavior of malignant struma ovarii does not necessarily indicate a histological malignancy, therefore, prediction of future metastasis is difficult and the optimal treatment strategy for malignant struma ovarii is controversial. The present case indicates that the long‑term use of oral anticancer agents may facilitate the maintenance of tumor dormancy.

View Figures

View References

1	Salvatori M, Dambra DP, D’Angelo G, Conte LL, Locantore P, Zannoni G, Campo V and Campo S: A case of metastatic struma ovarii treated with ¹³¹I therapy: focus on preservation of fertility and selected review of the literature. Gynecol Endocrinol. 24:312–319. 2008.
2	DeSimone CP, Lele SM and Modesitt SC: Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I¹³¹ therapy. Gynecol Oncol. 89:543–548. 2003.
3	Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS and Kim HS: Clinical characteristics of struma ovarii. J Gynecol Oncol. 19:135–138. 2008.
4	Devaney K, Snyder R, Norris HJ and Tavassoli FA: Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol. 12:333–343. 1993.
5	Steinman RA, De Castro IO, Shrayyef M, Chengazi V, Giampoli E, Van Der Sloot P, Calvi LM, et al: Two cases of malignant struma ovarii with metastasis to pelvic bone. Gynecol Obstet Invest. 75:139–144. 2013.
6	Dardik RB, Dardik M, Westra W and Montz FJ: Malignant struma ovarii: two case reports and a review of the literature. Gynecol Oncol. 73:447–451. 1999.
7	Heintz AP, Odicino F, Maisonneuve P, et al: Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological cancer. Int J Gynaecol Obstet. 95(Suppl 1): S161–S192. 2006.
8	Zakhem A, Aftimos G, Kreidy R and Salem P: Malignant struma ovarii: report of two cases and selected review of the literature. J Surg Oncol. 43:61–65. 1990.
9	Robboy SJ, Shaco-Levy R, Peng RY, Snyder MJ, Donahue J, Bentley RC, Bean S, et al: Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol. 28:405–422. 2009.
10	Makani S, Kim W and Gaba AR: Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol. 94:835–839. 2004.
11	Hatami M, Breining D, Owers RL, Del Priore G and Goldberg GL: Malignant struma ovarii - a case report and review of the literature. Gynecol Obstet Invest. 65:104–107. 2008.
12	Passler C, Scheuba C, Prager G, Kaczirek K, Kaserer K, Zetting G and Niederle B: Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer. 11:131–139. 2004.
13	Vadmal MS, Smilari TF, Lovecchio JL, Klein IL and Hajdu SI: Diagnosis and treatment of disseminated struma ovarii with malignant transformation. Gynecol Oncol. 64:541–546. 1997.
14	Brenner W, Bohuslavizki KH, Wolf H, Sippel C, Clausen M and Henze E: Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur J Nucl Med. 23:91–94. 1996.
15	Pardo-Mindan FJ and Vazquez JJ: Malignant struma ovarii. Light and electron microscopic study. Cancer. 51:337–343. 1983.
16	Sherman SI: Targeted therapy of thyroid cancer. Biochem Pharmacol. 80:592–601. 2010.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Long‑term survival in metastatic malignant struma ovarii treated with oral chemotherapy: A case report

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles